This Myasthenia Gravis Activities of Daily Living (MG-ADL) Symptom Tracker1 has been developed to help you monitor your gMG symptoms over time. Aim to complete your tracker regularly, ideally every week and on the same day each week. This will help your healthcare team better understand how gMG is affecting your daily life.

The MG-ADL Symptom Tracker has been developed to measure 8 common signs and symptoms of gMG related to everyday life. Answer the tracker questions based on the impact gMG has had on your quality of life over the past 7 days. Use this tracker as your reference, marking down the corresponding number for each activity on your Tracker Score Sheet. Add up the scores to calculate your weekly total in the bottom line of your Tracker Score Sheet and then transfer this total to the Symptom Tracker Graph, by marking it with a cross.

Here is an example of how your Symptom Tracker Score Sheet and Symptom Tracker Graph might look like:
Download
Download
This Myasthenia Gravis Quality of Life 15 (revised) Symptom Tracker2,3 (MG-QoL15r) has been developed to help you monitor your gMG symptoms over time. Aim to complete your tracker every 3 months or as agreed with your doctor. This will help your healthcare team better understand how gMG is affecting your daily life.

The MG-QoL15r Symptom Tracker has been developed to measure 15 common signs and symptoms of gMG related to everyday life. Answer the tracker questions based on the impact gMG has had on your quality of life over the past 4 weeks. Use this tracker as your reference, marking down the corresponding number for each activity on your Tracker Score Sheet. Add up the scores to calculate your total in the bottom line of your Tracker Score Sheet and then transfer this total to the Symptom Tracker Graph, by marking it with a cross.

Here is an example of how your Symptom Tracker Score Sheet and Symptom Tracker Graph might look like:
Download
Download
The information on this page is intended as educational information to be shared with your healthcare provider. It does not replace a healthcare provider’s judgement or clinical diagnosis.


  1. Wolfe GI, et al. Neurology. 1999;52(7):1487-1489.

  2. Burns TM, et al. Muscle Nerve. 2008;38(6):1553-1562.

  3. Burns TM, et al. Muscle Nerve. 2014;49(6):820-824.
The information on this website is provided by Alexion, AstraZeneca Rare Disease for educational purposes only and is for people prescribed an Alexion medicine. It is not intended nor implied to be a substitute for professional medical advice. If you have any questions about your medical condition, please talk to your doctor or other health care provider.
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the patient leaflet. You can also report side effects directly via the national reporting system [Country to add their Regulatory Authority website]. Side effects should also be reported to Alexion by contacting https://contactazmedical.astrazeneca.com. By reporting side effects, you can help provide information on the safety of this medicine.